HOME >> BIOLOGY >> NEWS
University of Toronto professor finds key protein in fight against plant disease

A University of Toronto botanist has identified a protein that ultimately could provide chemical-free ways to protect crops from disease.

"Finding this protein, called DIR1, could help make it possible to genetically engineer crops that resist disease-causing organisms," says Robin Cameron, a professor of botany at U of T and the senior investigator of the study, which appears in the Sept. 26 issue of Nature. "In the long run, having a better understanding of the whole process of disease resistance in plants could eliminate the need for fungicides or bacteriocides."

When disease strikes a plant, its immune system sends up a warning "flare" telling different areas of the plant to resist infection. "This process is kind of like vaccination, only better," Cameron says. Once the signal-dependant on DIR1-is triggered by one disease, it gives the plant systemic acquired resistance (SAR) to many other diseases. The exact role of DIR1 in the signal process is not yet clear, she says.

Cameron, along with colleagues at the Salk Institute in La Jolla, Calif., the John Innes Centre in Norwich, U.K. and the Noble Foundation in Ardmore, Okla., studied a mutant strain of weed with abnormal DIR1 that does not develop SAR when exposed to a certain bacterial disease. "Our studies indicate that the normal protein, DIR1, is required to either make or move the warning signal around the plant," she says.


'"/>

Contact: Nicolle Wahl
nicolle.wahl@utoronto.ca
416-978-6974
University of Toronto
25-Sep-2002


Page: 1

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/9/2016)... Paris Police Prefecture and ... ensure the safety of people and operations in several locations ... Teleste, an international technology group specialised in broadband ... its video security solution will be utilised by ... across the country. The system roll-out is scheduled for the ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... ... December 03, 2016 , ... Microbial genomics leader uBiome is ... has been made to Dr. Renato Polimanti of Yale University School of Medicine, ... microbiome. Grant proposals have been vetted by the company’s scientific review committee. ...
(Date:12/2/2016)... ... December 02, 2016 , ... In ... cervical and lumbar disc production, company President, Jake Lubinski will be traveling to ... the AxioMed disc in Bern, Lucerne, and Zurich to discuss the benefits of ...
(Date:12/2/2016)... Dec. 2, 2016 Amgen (NASDAQ: AMGN ... announced the submission of a Marketing Authorization Application (MAA) to ... candidate to Avastin ® (bevacizumab). The companies believe this ... EMA. "The submission of ABP 215 to ... expand our oncology portfolio," said Sean E. Harper , ...
(Date:12/2/2016)... , ... December 01, 2016 , ... ACEA Biosciences, Inc. ... Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, ... an update on the phase I/II clinical trials for AC0010 in patients with advanced ...
Breaking Biology Technology:
Cached News: